Peak Pharmaceuticals, Inc. (PKPH) Stock
Peak Pharmaceuticals, Inc., an American bio-pharmaceutical and nutraceutical company, specializes in the development, manufacturing, marketing, and sale of therapeutic products derived from hemp extracts. The firm particularly concentrates on formulating over-the-counter, THC-free, hemp-based remedies for human application, designed to help prevent and mitigate symptoms linked to inflammatory and auto-immune conditions.
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Peer Comparison
About Peak Pharmaceuticals, Inc.
Peak Pharmaceuticals, Inc., an American bio-pharmaceutical and nutraceutical company, specializes in the development, manufacturing, marketing, and sale of therapeutic products derived from hemp extracts. The firm particularly concentrates on formulating over-the-counter, THC-free, hemp-based remedies for human application, designed to help prevent and mitigate symptoms linked to inflammatory and auto-immune conditions. Originally established in 2007 as Cannabis Therapy Corporation, the company rebranded to Peak Pharmaceuticals, Inc. in December 2014 and maintains its main office in Scottsdale, Arizona.
Peak Pharmaceuticals, Inc. is headquartered in US.
Peak Pharmaceuticals, Inc. (PKPH) stock trades at $1.55 with a market capitalization of $607316. Over the past 52 weeks the stock has ranged between $1.35 and $43.80, and currently trades 96.5% below its 52-week high.